$109.50
4.944.72%
Ult. Agg.: Nov 10, 4:22 PM
The average analyst price target for Oruka Therapeutics is $87.06, 20.1% below the current price. Of 15 analysts, 15 rate it Buy. Targets range from $20 to $200. The latest change came on Jul 1, 2026, when UBS raised its price target on Oruka Therapeutics from $100 to $130 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months